Press Release July 8, 2021SHAREHOLDER ALERT: Robbins LLP Reminds Investors of a Class Action Against AcelRX Pharmaceuticals, Inc. (ACRX) 0 0 Share
Press Release July 5, 2021SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX 0 0 Share
Press Release July 4, 2021ROSEN, A TOP RANKED FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 9 Deadline in Securities Class Action - ACRX 0 0 Share
Press Release June 26, 2021Rosen, A Top Ranked Law Firm, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 9 Deadline in Securities Class Action - ACRX 0 0 Share
Press Release June 26, 2021The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of AcelRx Pharmaceuticals, Inc. (ACRX) Investors 0 0 Share
Press Release June 24, 2021ACRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds AcelRx Pharmaceuticals, Inc. Investors of Class Action and Encourages Investors to Contact the Firm 0 0 Share
Press Release June 23, 2021ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors With Losses Over $100K to Secure Counsel Before Important August 9 Deadline in Securities Class Action – ACRX 0 0 Share
Press Release June 22, 2021SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX 0 0 Share
Press Release June 20, 2021Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. (ACRX) 0 0 Share
Press Release June 18, 2021ACRX INVESTOR ALERT: ROSEN, A LEADING AND LONGSTANDING LAW FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ACRX 0 0 Share
